This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Sun Pharma Advanced Research Company Limited. Active years: 2020-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2023
Title: Gajanan Uttamrao Chidrewar: Innovator in Parkinson's Disease Treatment
Introduction
Gajanan Uttamrao Chidrewar is a notable inventor based in Baroda, India. He has made significant contributions to the field of medicine, particularly in the treatment of neurological disorders. With a total of 3 patents to his name, Chidrewar is recognized for his innovative approaches to healthcare.
Latest Patents
One of his latest patents focuses on a method for treating or preventing Parkinson's disease. This invention involves administering a compound of Formula I to subjects affected by the disease. His work aims to provide new therapeutic options for individuals suffering from this debilitating condition.
Career Highlights
Chidrewar is currently associated with Sun Pharma Advanced Research Company Limited, where he continues to develop groundbreaking treatments. His dedication to research and innovation has positioned him as a key figure in the pharmaceutical industry.
Collaborations
Throughout his career, Gajanan has collaborated with esteemed colleagues, including Nitin Krishnaji Damle and Sanjay Nandlalji Mandhane. These partnerships have further enhanced his research efforts and contributed to the advancement of medical science.
Conclusion
Gajanan Uttamrao Chidrewar's work in the treatment of Parkinson's disease exemplifies the impact of innovation in healthcare. His contributions are paving the way for new therapeutic strategies that can improve the quality of life for many individuals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile